Clinical Trial Update: Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair) [Phase 4]

View source ↗

Summary

Phase 4 trial update on using omalizumab (Xolair) for treating food allergy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• Omalizumab (Omalizumab)

Snippet

Sponsor: Carsten Bindslev-Jensen | Conditions: Food Allergy | Phase 4 | Status: COMPLETED